Selenium
Selenium is a chemical element investigated in biomedical research as a component of selenium-containing small molecules, selenium nanoparticles, selenium-doped carbon materials, and redox-responsive nanostructures.
Selenium is a chemical element investigated in biomedical research as a component of selenium-containing small molecules, selenium nanoparticles, selenium-doped carbon materials, and redox-responsive nanostructures. In the studies summarized here, its biological relevance is primarily associated with modulation of oxidative stress, reactive oxygen species, lipid peroxidation, mitochondrial dysfunction, DNA damage, apoptosis, and antioxidant signaling. Selenium-containing systems were also examined in relation to cellular uptake, drug delivery, immune responses, antimicrobial activity, and disease models involving acute kidney injury (AKI), cancer, cardiotoxicity, acute lung injury, infection, and neurodegenerative disease.
The recent literature represents a unified research area focused on selenium biomedical applications rather than distinct mechanistic subfields. Investigated platforms include sodium selenite-related selenium chemistry, selenium nanoparticles, selenium-doped carbon quantum dots, selenide-bridged nanoparticles, and selenium-containing drug candidates. Reported biological pathways and endpoints include nuclear factor erythroid 2-related factor 2 (NRF2) signaling, Keap-1 expression, p38/MAPK and unfolded protein response pathways, iron chelation, mitochondrial injury, and apoptosis. These findings are predominantly based on experimental therapeutic designs and do not, in the supplied publications, establish clinical efficacy or safety in humans.
Where the papers sit
9 papers from the last 6 months study selenium directly · updated from PubMed 3 Nov 2026
Study type 0 clinical trials · 1 observational · 8 preclinical
Themes one subject
Those 9 are all about one subject.
-
Selenium Biomedical Applications
Redox-active selenium compounds and nanomaterials are being explored across cancer, tissue injury, infection, and neurodegeneration. Recurring aims include restoring mitochondrial function, limiting oxidative damage, inducing apoptosis, modulating immunity, and improving targeted delivery. Cancer studies emphasize PD-L1 inhibition, topoisomerase I targeting, and overcoming p53-linked drug resistance, while other work tests antimicrobial and anti-inflammatory effects. The evidence remains broadly preclinical, with no single therapeutic direction yet dominating.
Papers
The 9 papers from the last 6 months that study selenium directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Selenium Biomedical Applications (9)
- Metallotoxicity-driven oxidative perturbations in spinal cord injury: Unraveling the pathophysiological nexus between metal-induced redox imbalance and disease severity: A correlational and multivariate analysis. Molecular biology reports · 15 Sept 2026 PMID 42742870
- Targeting mitochondrial dysfunction and apoptosis in 5-fluorouracil-induced cardiotoxicity using kaempferol-mediated selenium nanoparticles. Scientific reports · 12 Sept 2026 PMID 42732004
- Green-synthesized selenium and titanium dioxide nanomaterials: characterization and antimicrobial activity against multidrug-resistant pathogens. Die Naturwissenschaften · 25 Aug 2026 PMID 42640478
- Cellular hitchhiking of selenium carbon dots for targeted macrophage polarization in acute lung injury. Journal of materials chemistry. B · 7 Aug 2026 PMID 42565231
- Design, Synthesis, and Evaluation of Novel Phenoselenazine Derivatives as Potent Modulators of Aβ42 Aggregation. Journal of medicinal chemistry · 27 Jul 2026 PMID 42504619
- Engineered Reverse Growth of Metastable Electron-Rich Pd Clusters for Enhanced Catalytic/Sonodynamic/Immune Therapy. Advanced materials (Deerfield Beach, Fla.) · 22 Jul 2026 PMID 42483829
- Selenide-Bridged Redox-Responsive Nanoparticles: A Synergistic Strategy to Overcome p53 Mutation-Mediated Drug Resistance in Gastric Cancer. ACS nano · 21 Jul 2026 PMID 42478957
- Design, synthesis, and biological evaluation of novel selenium-matrine hybrid compounds as topo I -targeted anticancer agents. Bioorganic chemistry · 4 Jul 2026 PMID 42401165
- Novel Selenium-Containing Small Molecule PD-L1 Inhibitors: Design, Synthesis, and Evaluation of the Antitumor Activity. Journal of medicinal chemistry · 3 Jul 2026 PMID 42394434
By study type
Observational studies and case reports (1)
- Metallotoxicity-driven oxidative perturbations in spinal cord injury: Unraveling the pathophysiological nexus between metal-induced redox imbalance and disease severity: A correlational and multivariate analysis. Molecular biology reports · 15 Sept 2026 PMID 42742870
Preclinical: animal, cell and lab studies (8)
- Targeting mitochondrial dysfunction and apoptosis in 5-fluorouracil-induced cardiotoxicity using kaempferol-mediated selenium nanoparticles. Scientific reports · 12 Sept 2026 PMID 42732004
- Green-synthesized selenium and titanium dioxide nanomaterials: characterization and antimicrobial activity against multidrug-resistant pathogens. Die Naturwissenschaften · 25 Aug 2026 PMID 42640478
- Cellular hitchhiking of selenium carbon dots for targeted macrophage polarization in acute lung injury. Journal of materials chemistry. B · 7 Aug 2026 PMID 42565231
- Design, Synthesis, and Evaluation of Novel Phenoselenazine Derivatives as Potent Modulators of Aβ42 Aggregation. Journal of medicinal chemistry · 27 Jul 2026 PMID 42504619
- Engineered Reverse Growth of Metastable Electron-Rich Pd Clusters for Enhanced Catalytic/Sonodynamic/Immune Therapy. Advanced materials (Deerfield Beach, Fla.) · 22 Jul 2026 PMID 42483829
- Selenide-Bridged Redox-Responsive Nanoparticles: A Synergistic Strategy to Overcome p53 Mutation-Mediated Drug Resistance in Gastric Cancer. ACS nano · 21 Jul 2026 PMID 42478957
- Design, synthesis, and biological evaluation of novel selenium-matrine hybrid compounds as topo I -targeted anticancer agents. Bioorganic chemistry · 4 Jul 2026 PMID 42401165
- Novel Selenium-Containing Small Molecule PD-L1 Inhibitors: Design, Synthesis, and Evaluation of the Antitumor Activity. Journal of medicinal chemistry · 3 Jul 2026 PMID 42394434
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-09-16. Last written: 2026-09-17 by GPT. Drafted by language models from published abstracts; not medical advice.